Greenlight's David Einhorn dumps most of Peloton stake, adds big industrial bet
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
24 minutes ago
- CNBC
5 stocks to buy as the S&P 500 nears record highs, plus updates on 26 other names
Jim Cramer covered each holding in the Investing Club's portfolio during the August Monthly Meeting on Thursday. He went over five stocks new investors should consider buying — and when to sell others – as the S & P 500 trades near record highs. Apple: This stock has had a big rally following the company's announcement last week of an additional $100 billion investment in U.S. manufacturing. It just goes to show: Don't give up on Apple. The next major test will come if a U.S. judge in Alphabet's antitrust case ends its search exclusivity deal with the iPhone maker. If that happens, Apple management will have to come up with a plan to offset the $20 billion worth of annual payments from Alphabet. We remain confident and maintain our "hold, don't trade" thesis on the stock. Amazon: The company's cloud computing division, Amazon Web Services, isn't growing as fast as hoped. That was seen in second-quarter earnings late last month. Still, we're staying long on the stock. AWS is a huge business, and demand for cloud infrastructure is incredibly high. Abbott Laboratories: We've been selling down the position on the belief that Abbott just doesn't have the same oomph that it used to. Its recent earnings report suggested the headwinds in China could be more prolonged than previously thought. Jim said if it fell much further, we'd consider rebuilding the position. Broadcom: This company is one of the linchpins of the AI trade thanks to its custom chips and networking equipment. The scale of the AI buildout is so immense that, despite all the negatives, we just have to plow through and the stay the course. We did trim our Broadcom position for a big gain on Aug. 6, to not be greedy. BlackRock: The financial stock is well positioned for more upside as the broader equities market continues to trade near record highs. That's because BlackRock shares typically work best in a portfolio when assets are growing from appreciation and contributions. Bristol Myers Squibb: Could the rise in M & A activity and a more hands-off approach from antitrust regulators put Bristol Myers in play? Jim says it's possible, though not certain. A forthcoming trial on its new schizophrenia drug Cobenfy could help quell some concerns about its commercial potential that arose after prior results fell short of investor expectations. Capital One: If the U.S. economy goes south, Capital One could get hit because it's heavily levered to the health of the consumer. So far, however, there are no serious warning signs that could impact credit quality. Additionally, we continue to celebrate Capital One's recently-completed blockbuster acquisition of Discover Financial. Costco: This is a great stock to own during macroeconomic uncertainty, as the wholesale retailer attracts value-conscious customers. "When times get tough, people go to Costco," Jim said. Investors should consider buying more. Salesforce: The idea that "AI is eating software" has won over Wall Street, and the argument has its merits, as we explored earlier this week . We accordingly downgraded our rating on Salesforce. But we're not ready to bail altogether. We want to see the latest revenue contributions from Agentforce in its upcoming earnings report, and its big annual Dreamforce conference this fall has historically been a positive catalyst. CrowdStrike: Investors should consider buying CrowdStrike as shares tumble due to a broad slump in the cybersecurity sector. The stock's move lower, however, has nothing to do with the company's fundamentals. That's why it's a solid time to capitalize on the dip. Cisco Systems: This is our newest addition to the Club's portfolio, which we initiated on July 17. The computer networking equipment powerhouse has a big opportunity to benefit from AI. Plus, the firm has a strong track record of returning capital to shareholders. Cisco posted a top and bottom line beat Wednesday evening. The company, however, missed revenue estimates for its security segment, which sent shares lower. It didn't change our thesis on the stock though. Coterra Energy: This stock has become a cruise to nowhere, and we opted to exit the rest of our small remaining position. It's a tough market for the underlying commodities that Coterra depends on for revenue, and operational issues caught us by surprise too. DuPont: Shares are in a lull ahead of DuPont's forthcoming breakup, experiencing what many on Wall Street call "spin purgatory." Although we don't know with certainty when the stock will pick up again, it will happen in a span of days, rather than weeks or months. That means investors should buy DuPont stock again anytime it dips lower ahead of the split. Danaher: We're holding this lagging stock as we await more clarity on potential catalysts. The company could spring back to life if an IPO window opens for biotech, which could boost orders for Danaher. That being said, Danaher's increased focus on life sciences has made the firm lose some of its optionality. Disney: New to the Club? Disney is one to buy. Theme parks are strong, movies are very good and streaming is fine. Nothing is great enough to lift the stock to the $130s. But it most certainly belongs in the $120s. Dover: It's been a lackluster 2025 for Dover, with shares down 4.5% year to date. But more aggressive portfolio management could be a way to improve investor sentiment. By divesting one of its far-flung businesses, management could unlock more value. Eaton: This stock's performance has been nowhere near impressive as of late, but members should stick with Eaton. The industrial conglomerate has decent exposure to secular growth themes with its aerospace and data center businesses. Jim, however, wishes management would split the company in two because it's more difficult for them to create value together. GE Vernova: This power equipment maker has a huge growth opportunity as the data center build out continues to raise demand for offerings like gas turbines. "Here's a stock that almost seems to be invented for this moment," Jim said of GE Vernova. He isn't happy, however, that management has been resistant to adding production capacity for its turbines. Goldman Sachs: This might be "one of the cheapest stocks" the Club owns, Jim said. That's because shares will be worth much more as Wall Street dealmaking picks up. More IPOs and M & A deals can lead to an upside to revenue for Goldman's highly lucrative investment banking business. Home Depot: With rates still high, this retailer has had a lackluster stock performance. That being said, Home Depot is the ideal stock to own during an interest-rate-cutting cycle. Lower borrowing costs should cause a much-needed rebound in the housing market, which means more business for Home Depot. Honeywell International: Yet again, Jim pounded the table on Honeywell's spinoff into three public companies. "The three pieces could be worth dramatically more than the stock is selling for," he said. "My conviction is very high for this." Let's hope it helps its share price, too. Honeywell stock has underperformed the market in 2025, down nearly 3% year to date versus the S & P 500's 9.7% gain. Linde: Jim described Linde as the "perfect industrial." The company continues to thrive in various macro backdrops, as seen in its many consecutive beat-and-raise quarters. Plus, Linde's immense pricing power makes us love the stock even more. Eli Lilly: We double upgraded Lilly on Wednesday after a great sign of confidence from management and the board of directors in buying up a bunch of stock in the open market. While it's usually not our style to adjust the rating so soon after we downgraded it, when the facts change, we must change with them. Meta Platforms: Buy this stock on its next dip. Meta shares could run higher if management effectively monetizes WhatsApp. The social media behemoth has made recent strides to turn WhatsApp into a moneymaker by rolling out advertisements back in June. Meta clearly has the toolbox to make another great ads business. Just look at the reach of the company's platforms like Instagram and Facebook. Microsoft: We recommend members buy shares on any weakness. The firm had a picture perfect quarterly earning report in late July, fueled by accelerated revenue growth in its cloud computing business. This put to bed any question of Microsoft's leadership in generative AI. Nvidia: The company reports on Aug. 27, and this quarter at least will hinge on how well they're meeting demand for Blackwell chips rather than its China business. As with Broadcom, the size of the AI buildout and the money that will flow to Nvidia makes the stock a must-own. Palo Alto Networks: Shares have been weighed down by weakness in cyber, along with concerns about management's intent to acquire CyberArk. The market's reaction is overblown though. "I feel very good about this situation," Jim said of Palo Alto. Starbucks: This is Jim's favorite consumer-facing stock we own right now. Patience is required on the turnaround, led by CEO Brian Niccol, because when things really get better, it will be too late to buy. TJX Companies: There's nothing to do with TJX ahead of earnings next week. After a two-month downtrend, the stock has climbed back up into the low-to-mid $130s. We were right to stay the course despite those worrying about a technical breakdown. Texas Roadhouse: Investors should "buy this one aggressively," Jim said. Although elevated beef prices weighed on profitability in the second quarter, the restaurant chain has great revenue growth and has executed well on what it can control. Plus, there's no telling when we'll see Texas Roadhouse stock this low again following its earnings-induced selloff last week. Wells Fargo: This bank stock is undervalued. Jim said he'd buy some now if the portfolio didn't own any. He forecasted that shares could rally past its record highs, and still not be too expensive. Plus, Wells has a decent chance to grab more M & A deals moving forward now that its $1.95 trillion asset cap has been removed. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Yahoo
an hour ago
- Yahoo
Robert Bruce's Strategic Move: LyondellBasell Industries NV Takes Center Stage
Exploring the Latest 13F Filing and Investment Adjustments Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Robert Bruce (Trades, Portfolio) is the founder of Bruce & Co, the investment firm that serves as the advisor to the Bruce Fund (BRUFX). The Bruce Fund is run by Robert Bruce (Trades, Portfolio) and his son, Robert Jeffrey Bruce. The Fund focuses primarily on common stock investments, though it also invests in high-yield and distressed debt. It may invest in some long-term U.S. government securities if the managers cannot find attractive opportunities elsewhere. The Fund invests mostly in small- and mid-cap stocks, with the occasional large-cap, as well as convertible and distressed bonds. The Bruces tend to hold their stocks for the long-term, generally preferring the securities of distressed companies that are trading at a significant discount but which they believe can make a turnaround. Summary of New Buy Robert Bruce (Trades, Portfolio) added a total of 1 stock, among them: The most significant addition was LyondellBasell Industries NV (NYSE:LYB), with 40,000 shares, accounting for 0.75% of the portfolio and a total value of $2.31 million. Key Position Increases Robert Bruce (Trades, Portfolio) also increased stakes in a total of 2 stocks, among them: The most notable increase was Vicor Corp (NASDAQ:VICR), with an additional 20,000 shares, bringing the total to 90,000 shares. This adjustment represents a significant 28.57% increase in share count, a 0.3% impact on the current portfolio, with a total value of $4,082,400. The second largest increase was The Chemours Co (NYSE:CC), with an additional 50,000 shares, bringing the total to 250,000. This adjustment represents a significant 25% increase in share count, with a total value of $2,862,500. Summary of Sold Out Robert Bruce (Trades, Portfolio) completely exited 2 of the holdings in the second quarter of 2025, as detailed below: Organon & Co (NYSE:OGN): Robert Bruce (Trades, Portfolio) sold all 31,200 shares, resulting in a -0.15% impact on the portfolio. IGM Biosciences Inc (NASDAQ:IGMS): Robert Bruce (Trades, Portfolio) liquidated all 100,000 shares, causing a -0.04% impact on the portfolio. Key Position Reduces Robert Bruce (Trades, Portfolio) also reduced positions in 4 stocks. The most significant changes include: Reduced CMS Energy Corp (NYSE:CMS) by 30,000 shares, resulting in a -13.27% decrease in shares and a -0.73% impact on the portfolio. The stock traded at an average price of $71.31 during the quarter and has returned 6.67% over the past 3 months and 11.79% year-to-date. Reduced Merck & Co Inc (NYSE:MRK) by 10,000 shares, resulting in a -4.93% reduction in shares and a -0.29% impact on the portfolio. The stock traded at an average price of $79.65 during the quarter and has returned 13.43% over the past 3 months and -15.50% year-to-date. Portfolio Overview At the second quarter of 2025, Robert Bruce (Trades, Portfolio)'s portfolio included 40 stocks, with top holdings including 8.21% in Allstate Corp (NYSE:ALL), 7.98% in U-Haul Holding Co (NYSE:UHAL.B), 7.69% in AbbVie Inc (NYSE:ABBV), 7.1% in NextEra Energy Inc (NYSE:NEE), and 6.97% in AerCap Holdings NV (NYSE:AER). The holdings are mainly concentrated in 9 of all the 11 industries: Utilities, Healthcare, Industrials, Financial Services, Communication Services, Consumer Defensive, Technology, Basic Materials, and Energy. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Yahoo
an hour ago
- Yahoo
Ken Fisher's Strategic Moves: Oracle Corp Sees Significant Reduction
Exploring Ken Fisher (Trades, Portfolio)'s Latest 13F Filing and Investment Adjustments Warning! GuruFocus has detected 5 Warning Signs with NVDA. Ken Fisher (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Ken Fisher (Trades, Portfolio) is the Chief Executive Officer and Chief Investment Officer of Fisher Investments. He has been writing Forbes' prestigious "Portfolio Strategy" column for over two decades, making him one of the longest-running columnists in the magazine's 85+ year history. During his many years of money management and market commentary, Ken has distinguished himself by making numerous, accurate market calls, often in direct opposition to Wall Street's consensus forecast. He is the son of legendary investor Philip A. Fisher, and Ken is the only industry professional his father ever trained. Ken has also written three major finance books, including the 1984 Dow Jones best-seller, Super Stocks, and has been published and/or interviewed in many major global finance and business periodicals. The investment philosophy at Fisher Investments is based on the idea that supply and demand of securities is the sole determinant of their pricing. Furthermore, they believe that all widely known information has already been priced into the market. The way to add value, according to the Fisher strategy, is to "identify information not widely known, or to interpret widely known information differently and correctly from other market participants." Fisher Investments employs a team of research analysts to accomplish these tasks. Summary of New Buy Ken Fisher (Trades, Portfolio) added a total of 94 stocks, among them: The most significant addition was Canadian National Railway Co (NYSE:CNI), with 1,823,800 shares, accounting for 0.08% of the portfolio and a total value of $189.75 million. The second largest addition to the portfolio was Canadian Imperial Bank of Commerce (NYSE:CM), consisting of 1,251,017 shares, representing approximately 0.04% of the portfolio, with a total value of $88.61 million. The third largest addition was Adtalem Global Education Inc (NYSE:ATGE), with 335,605 shares, accounting for 0.02% of the portfolio and a total value of $42.70 million. Key Position Increases Ken Fisher (Trades, Portfolio) also increased stakes in a total of 332 stocks, among them: The most notable increase was Royal Bank of Canada (NYSE:RY), with an additional 5,289,330 shares, bringing the total to 5,723,581 shares. This adjustment represents a significant 1,218.04% increase in share count, a 0.28% impact on the current portfolio, with a total value of $752.94 million. The second largest increase was Sony Group Corp (NYSE:SONY), with an additional 16,280,542 shares, bringing the total to 101,878,066. This adjustment represents a significant 19.02% increase in share count, with a total value of $2.65 billion. Summary of Sold Out Ken Fisher (Trades, Portfolio) completely exited 107 of the holdings in the second quarter of 2025, as detailed below: Charles River Laboratories International Inc (NYSE:CRL): Ken Fisher (Trades, Portfolio) sold all 255,223 shares, resulting in a -0.02% impact on the portfolio. Tenable Holdings Inc (NASDAQ:TENB): Ken Fisher (Trades, Portfolio) liquidated all 1,233,591 shares, causing a -0.02% impact on the portfolio. Key Position Reduces Ken Fisher (Trades, Portfolio) also reduced positions in 522 stocks. The most significant changes include: Reduced Oracle Corp (NYSE:ORCL) by 8,714,141 shares, resulting in a -49.51% decrease in shares and a -0.53% impact on the portfolio. The stock traded at an average price of $161.13 during the quarter and has returned 50.54% over the past 3 months and 48.10% year-to-date. Reduced Salesforce Inc (NYSE:CRM) by 3,824,987 shares, resulting in a -47.5% reduction in shares and a -0.45% impact on the portfolio. The stock traded at an average price of $267.36 during the quarter and has returned -19.04% over the past 3 months and -29.48% year-to-date. Portfolio Overview At the second quarter of 2025, Ken Fisher (Trades, Portfolio)'s portfolio included 986 stocks, with top holdings including 5.18% in NVIDIA Corp (NASDAQ:NVDA), 4.8% in Microsoft Corp (NASDAQ:MSFT), 4.36% in Apple Inc (NASDAQ:AAPL), 3.37% in Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT), and 2.83% in Inc (NASDAQ:AMZN). The holdings are mainly concentrated in 10 of all the 11 industries: Technology, Financial Services, Industrials, Healthcare, Communication Services, Consumer Cyclical, Energy, Consumer Defensive, Basic Materials, and Real Estate. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
